Li AM, Hucks GE, Dinofia AM, et al. Checkpoint inhibitors augment CD19-directed chimeric antigen receptor (CAR) T cell therapy in relapsed B-cell acute lymphoblastic leukemia. ASH Annual Meeting and Exposition 2018, abstract 556.
Slechtere prognose bij ALL door downsyndroom en IKZF1-deletie
jan 2022 | Leukemie